July 21, 2021
The Ministry of Health, Labor and Welfare (MHLW) on July 20 ordered label revisions to add new side effect risks for a group of treatments for bone diseases including Astellas Pharma’s osteoporosis treatment Evenity (romosozumab). The bone disease drugs subject...read more